Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

McMaster University

$100,000.00

Pharmacogenetics of Methadone Maintenance Treatment Response

EF 2016-17

Résumé
Opioids are commonly prescribed medications for the management of pain, but have very high liability for misuse and addiction. High rates of opioid prescribing have led to epidemic levels of opioid use disorder (OUD) and opioid-related morbidity and mortality in Canada. There are relatively few treatment options for OUD and the most common is substitution with methadone (methadone maintenance treatment, MMT), a synthetic opioid. However, MMT outcomes vary greatly, with the average patient receiving MMT for multiple years and many continuing to use opioids while on MMT. Furthermore, MMT itself also carries significant health risks, including high-rates of mortality. There is preliminary evidence that differences in MMT response are partially determined by genetic variation. Identifying how genes affect the response to methadone has the potential to substantially improve the OUD treatment outcomes via a personalized medicine approach. Toward this end, the proposed study will leverage innovations in genomic approaches to systematically examine individual variation in MMT response in a large sample of OUD MMT patients. Our hypothesis is that MMT outcomes are significantly determined by genetic variants that can inform future treatment decisions and the study's superordinate goal is to rigorously test this hypothesis using multiple methodologies.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
366659
Name
MacKillop James
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Project Grant Competition
Projecttitle
Pharmacogenetics of Methadone Maintenance Treatment Response
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Addiction; Methadone; Opioid Use Disorder; Personalized Medicine; Pharmacogenetics; Pharmacotherapy; Precision Medicine; Prognosis; Treatment
Abstract
Opioids are commonly prescribed medications for the management of pain, but have very high liability for misuse and addiction. High rates of opioid prescribing have led to epidemic levels of opioid use disorder (OUD) and opioid-related morbidity and mortality in Canada. There are relatively few treatment options for OUD and the most common is substitution with methadone (methadone maintenance treatment, MMT), a synthetic opioid. However, MMT outcomes vary greatly, with the average patient receiving MMT for multiple years and many continuing to use opioids while on MMT. Furthermore, MMT itself also carries significant health risks, including high-rates of mortality. There is preliminary evidence that differences in MMT response are partially determined by genetic variation. Identifying how genes affect the response to methadone has the potential to substantially improve the OUD treatment outcomes via a personalized medicine approach. Toward this end, the proposed study will leverage innovations in genomic approaches to systematically examine individual variation in MMT response in a large sample of OUD MMT patients. Our hypothesis is that MMT outcomes are significantly determined by genetic variants that can inform future treatment decisions and the study's superordinate goal is to rigorously test this hypothesis using multiple methodologies.
Competitiondate
201611
Approvedterm2
1 yr 0 mth
Pinamesdelim
MacKillop, James; Samaan, Zainab
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~